Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
5,782,525
-
Total 13F shares
-
100,658
-
Share change
-
+36,026
-
Total reported value
-
$81,474
-
Price per share
-
$0.81
-
Number of holders
-
5
-
Value change
-
+$27,883
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX) as of Q3 2025
As of 30 Sep 2025,
XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,658 shares.
The largest 5 holders included
CITADEL ADVISORS LLC, XTX Topco Ltd, Clearstead Advisors, LLC, UBS Group AG, and SBI Securities Co., Ltd..
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.